J
John R. Ingram
Researcher at Cardiff University
Publications - 160
Citations - 3218
John R. Ingram is an academic researcher from Cardiff University. The author has contributed to research in topics: Hidradenitis suppurativa & Medicine. The author has an hindex of 26, co-authored 129 publications receiving 2129 citations. Previous affiliations of John R. Ingram include University Hospital of Wales & Cardiff and Vale University Health Board.
Papers
More filters
Journal ArticleDOI
Para-phenylenediamine allergy: current perspectives on diagnosis and management
TL;DR: Hairdressers are at a high risk for PPD allergy and require counseling regarding techniques to minimize exposure and protective measures while handling hair dye, and this review focuses on the current perspectives of diagnosis and management.
Journal ArticleDOI
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.
Mark Rodgers,Susan Griffin,Mike Paulden,Russell Slack,Steven Duffy,John R. Ingram,Nerys Woolacott,Mark Sculpher +7 more
TL;DR: The ERG concluded that, although the evidence presented indicates that alitretinoin is efficacious in the treatment of severe CHE, it gives little indication of alit retinoin’s efficacy relative to likely alternative treatment options or its efficacy and safety in the longer term.
Journal ArticleDOI
The Hidradenitis Suppurativa Priority Setting Partnership
TL;DR: Hidradenitis suppurativa has been neglected by medical researchers and society in general, despite being a relatively common, painful, chronic skin disease.
Journal ArticleDOI
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
L. Thorlacius,L. Thorlacius,Amit Garg,Peter Theut Riis,Sabrina Mai Nielsen,Vincenzo Bettoli,John R. Ingram,V. Del Marmol,Lukasz Matusiak,José C. Pascual,Jean Revuz,Karin Sartorius,Thrasyvoulos Tzellos,H.H. van der Zee,Christos C. Zouboulis,Ditte Marie Saunte,Alice B. Gottlieb,Robin Christensen,Robin Christensen,Gregor B.E. Jemec +19 more
TL;DR: Monitoring disease activity over time is a prerequisite for clinical practice and research and valid and reliable outcome measurement instruments (OMIs) and staging systems provide researchers and clinicians with benchmark tools to assess the primary and secondary outcomes of interventional trials.
Journal ArticleDOI
Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey.
TL;DR: In this article, a prospective cross-sectional global online survey using social media was conducted to measure the impact of COVID-19 on the quality of life (QoL) of survivors and their partners and family members.